Standard BioTools Inc. Interest Paid, Including Capitalized Interest, Operating and Investing Activities
Standard BioTools Inc. (LAB) reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $5.53 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaid · last filed 2018-03-08
- Standard BioTools Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2012-03-31 was $281.00K, a 43.12% decline year-over-year.
- Standard BioTools Inc. interest paid, including capitalized interest, operating and investing activities for the quarter ending 2011-03-31 was $494.00K.
- Standard BioTools Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2017 was $5.53M, a 0.00% change from fiscal 2016.
- Standard BioTools Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2016 was $5.53M, a 0.07% decline from fiscal 2015.
- Standard BioTools Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2015 was $5.54M, a 101.38% increase from fiscal 2014.
- Standard BioTools Inc. interest paid, including capitalized interest, operating and investing activities for fiscal 2014 was $2.75M, a 39185.71% increase from fiscal 2013.
| Period end | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 3 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month |
|---|---|---|
| 2017-12-31 | $5.53M 10-K · filed 2018-03-08 | |
| 2016-12-31 | $5.53M 10-K · filed 2018-03-08 | |
| 2015-12-31 | $5.54M 10-K · filed 2018-03-08 | |
| 2014-12-31 | $2.75M 10-K · filed 2017-03-03 | |
| 2013-12-31 | $7.00K 10-K · filed 2016-02-29 | |
| 2012-12-31 | $579.00K 10-K · filed 2015-02-26 | |
| 2012-03-31 | $281.00K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.72M 10-K · filed 2014-03-12 | |
| 2011-03-31 | $494.00K 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $1.77M 10-K · filed 2013-03-12 | |
| 2009-12-31 | $1.94M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |